Application 062279

Type
ANDA
Sponsor
VALEANT LUXEMBOURG

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001GRIFULVIN VGRISEOFULVIN, MICROCRYSTALLINETABLET;ORAL125MGNoNo
002GRIFULVIN VGRISEOFULVIN, MICROCRYSTALLINETABLET;ORAL250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**NoNo
003GRIFULVIN VGRISEOFULVIN, MICROSIZETABLET;ORAL500MGNoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
18307SUPPL2014-04-10
42759SUPPL2005-07-22